P450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR-MDS. (23rd June 2022) - Pakulska, U.; Angelosanto, N.; Mikula, M.; Nogai, H.; Dudziak, R.; Abboud, C.; Obacz, M.; Goller, K.; Cybulska, M.; Mazan, M.; Kozakowska, M.; Rzymski, T.